News

For patients with brain arteriovenous malformations, not having surgery or getting radiation therapy can result in an almost 70-per-cent lower risk of...

With a new study on re-using cardiac medical devices, the eldest son of two UdeM health professionals becomes the youngest author ever published in...

A new test developed at CHU Sainte-Justine will enable better management of patients with severe combined immunodeficiency (SCID).

By depositing a saliva sample on a tiny device attached to your smartphone, you could find out in five minutes if you’re infected, say pharmacists at...

Three weeks after onset, more than 90% of infected people have antibodies that recognize one of the hallmarks of SARS-CoV-2, the S glycoprotein.

A new UdeM-led report says the world’s universities need to exercise strong leadership in developing digital technologies and artificial intelligence...

In a live broadcast, three UdeM professors discuss the technical, health and legal implications of a new smartphone application developed at Mila to...

Run from UdeM’s School of Social Work, the Observatoire sur les profilages gets a $2.5-million grant from the Social Sciences and Humanities Research...

The Institute for Research in Immunology and Cancer (IRIC) of the Université de Montréal is proud to announce that David Knapp and Geneviève Deblois...

Université de Montréal researchers discover how a key cancer mutation activates telomerase, the ‘anti-aging enzyme’ that makes tumour cells immortal.

Université de Montréal / Research

Doing no harm reduces the risk of stroke

‘His heart’s in the right place’

For babies born with a rare immune deficiency, a unique new test to better target care

A fast self-test for COVID-19

COVID-19: the number of antibodies neutralizing the virus decreases after six weeks

Innovating in a digital world

Contact-tracing to save lives

$2.5M for research on discriminatory profiling

Geneviève Deblois and David Knapp become IRIC researchers

Tracking cancer’s immortality factor